Seeking Alpha

EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis

LYON, France, March 4, 2024 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, announced today that its Focal One platform has been granted Breakthrough Device designation by ...
Nasdaq

EDAP Announces Sale of Robotic Focal One® HIFU Device to University of Miami

LYON, France, January 29, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the University of Miami Sylvester Comprehensive ...
Seeking Alpha

EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis

LYON, France, January 31, 2022 -- EDAP TMS SA (EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced positive clinical results from the Endo-HIFU-R1 Phase 2 study ...
Business Insider

EDAP Selects Leading Reimbursement Consultancies MTP and Argenta Advisors to Expand Market Access and Coverage of HIFU in the US

LYON, France, March 3, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announces today that the company has selected Medical Technology ...
Business Insider

EDAP Announces Two Publications Highlighting Favorable HIFU Focal Therapy Outcomes in Journal of Urology

Studies conducted at the University of Southern California and University of Miami represent the first U.S. publications detailing successful partial-gland ablation using high intensity focused ...
Mena FN

Industry Analysis: 5-In-1 HIFU Technology And China's Export-Oriented Manufacturing Landscape

(MENAFN- EIN Presswire) EINPresswire/ -- I. Company Overview: Huamei's Leadership in Advanced Aesthetic Technology Located in Shandong, China, Shandong Huamei Technology Co., Ltd. has established ...